nach oben

Rheumatology International

Erschienen in:

23.10.2018 | Case Based Review

Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review

verfasst von: Rada Miskovic, Aleksandra Plavsic, Jasna Bolpacic, Sanvila Raskovic, Jovan Ranin, Mirjana Bogic

Erschienen in: Rheumatology International | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

A possible association between strongyloidiasis and systemic vasculitis is rarely reported in the literature. We report the case of a patient with severe strongyloidiasis and an angiographic finding consistent with polyarteritis nodosa. Diagnosis of strongyloidiasis was made by finding of larvae and adult parasites in samples of the upper gastrointestinal tract mucosa and stool. The patient was treated with albendazole, ivermectin and corticosteroid withdrawal. This therapy led to the resolution of symptoms, with repeated stool samples negative for S. stercoralis. However, the clinical course was complicated with pulmonary tuberculosis. Despite tuberculostatic therapy and supportive measures, a lethal outcome occurred. The report is followed by a focused review of the available literature on the association of strongyloidiasis and systemic vasculitis.

Genta RM (1989) Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 11:755–767CrossRef

Siddiqui AA, Berk SL (2001) Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33:1040–1047. https://doi.org/10.1086/322707 CrossRefPubMed

Mejia R, Nutman TB (2012) Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 25:458–463. https://doi.org/10.1097/qco.0b013e3283551dbd CrossRefPubMedPubMedCentral

Somer T, Finegold SM (1995) Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 20:1010–1036CrossRef

Bocanegra TS, Vasey FB (1993) Musculoskeletal syndromes in parasitic diseases. Rheum Dis Clin N Am 19:505–513

Peng SL (2002) Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum 31:228–247CrossRef

Hamidou MA, Fradet G, Kadi A-M et al (2002) Systemic vasculitis with lymphocytic temporal arteritis and Toxocara canis infection. Arch Intern Med 162:1521–1524CrossRef

Chauhan A, Scott DGI, Neuberger J et al (1990) Churg–Strauss vasculitis and ascaris infection. Ann Rheum Dis 49:320–322CrossRef

Patey O, Bouhali R, Breuil J et al (1990) Arthritis associated with Strongyloides stercoralis. Scand J Infect Dis 22:233–236CrossRef

10.

Brocq O, Breuil V, Agopian V et al (1996) Reactive arthritis induced by Strongyloides stercoralis. Rev Rhum Engl Ed 63:217–219PubMed

11.

van Kuijk AWR, Kerstens PJSM, Perenboom RM et al (2003) Early-onset polyarthritis as presenting feature of intestinal infection with Strongyloides stercoralis. Rheumatology 42:1419–1420. https://doi.org/10.1093/rheumatology/keg348 CrossRefPubMed

12.

Wachter RM, Burke AM, MacGregor RR (1984) Strongyloides stercoralis hyperinfection masquerading as cerebral vasculitis. Arch Neurol 41:1213–1216CrossRef

13.

Reiman S, Fisher R, Dodds C et al (2002) Mesenteric arteriographic findings in a patient with Strongyloides stercoralis hyperinfection. J Virol 13:635–638. https://doi.org/10.1016/S1051-0443(07)61660-1 CrossRef

14.

Masseau A, Hervier B, Leclair F et al (2005) Strongyloides stercoralis infection simulating polyarteritis nodosa. La Rev Med Intern 26:661–663. https://doi.org/10.1016/j.revmed.2005.05.003 CrossRef

15.

Csermely L, Jaafar H, Kristensen J et al (2006) Strongyloides hyper-infection causing life-threatening gastrointestinal bleeding. World J Gastroenterol 12:6401–6404CrossRef

16.

Janković S, Nikolić M, Simović A, Vujić A (2016) Henoch–Schönlein purpura associated with Strongyloides stercoralis infection. Vojnosanit Pregl 73:491–495CrossRef

17.

Pagnoux C, Cohen P, Guillevin L (2006) Vasculitides secondary to infections. Clin Exp Rheumatol 24:(2Suppl):S71–S81PubMed

18.

Ramdial PK, Hlatshwayo NH, Singh B (2006) Strongyloides stercoralis mesenteric lymphadenopathy: clue to the etiopathogenesis of intestinal pseudo-obstruction in HIV-infected patients. Ann Diagn Pathol 10:209–214. https://doi.org/10.1016/j.anndiagpath.2005.11.008 CrossRefPubMed

19.

Chunlertrith K, Noiprasit A, Kularbkaew C et al (2015) A complicated case of Strongyloidiasis presenting with intestinal lymphadenopathy obstruction: molecular identification. Southeast Asian J Trop Med Public Health 46:1–7PubMed

20.

Aragon S, Valero J, Jaramillo LE (2017) Intestinal mass in a one year old child: an unusual presentation of Strongyloides stercolaris infection. Case report. J Pediatr Surg Case Rep 20:29–32. https://doi.org/10.1016/J.EPSC.2017.03.005 CrossRef

21.

Iwashita Y, Suzuki K, Masui A et al (2013) A case of Strongyloides hyperinfection associated with tuberculosis. J Intensive Care 1(1):7. https://doi.org/10.1186/2052-0492-1-7 CrossRefPubMedPubMedCentral

22.

Elias D, Mengistu G, Akuffo H, Britton S (2006) Are intestinal helminths risk factors for developing active tuberculosis? Trop Med Int Health 11:551–558. https://doi.org/10.1111/j.1365-3156.2006.01578.x CrossRefPubMed

23.

Resende Co T, Hirsch CS, Toossi Z et al (2006) Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol 147(1):45–52. https://doi.org/10.1111/j.1365-2249.2006.03247.x CrossRef

24.

Li X-X, Zhou X-N (2013) Co-infection of tuberculosis and parasitic diseases in humans: a systematic review. Parasit Vectors 6:79. https://doi.org/10.1186/1756-3305-6-79 CrossRefPubMedPubMedCentral

25.

Satoguina J, Mempel M, Larbi J et al (2002) Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 4:1291–1300CrossRef

26.

Kiyuna M, Toda T, Tamamoto T et al (1994) An autopsy case of periarteritis nodosa associated with disseminated strongyloidiasis. Rinsho Byori 42:883–887PubMed

27.

Fardet L, Généreau T, Poirot J-L et al (2007) Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect 54:18–27. https://doi.org/10.1016/j.jinf.2006.01.016 CrossRefPubMed

28.

Santiago M, Leitão B, Leitao B (2009) Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view. Eur J Intern Med 20(8):744–748CrossRef

Titel: Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review
verfasst von: Rada Miskovic
Aleksandra Plavsic
Jasna Bolpacic
Sanvila Raskovic
Jovan Ranin
Mirjana Bogic
Publikationsdatum: 23.10.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 12/2018
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-018-4178-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelines

Fibromyalgia as a challenge for patients and physicians

Efficacy and safety of extending intravenous tocilizumab intervals from 4 to 6 weeks in rheumatoid arthritis patients with good response to 4-week intervals

High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome

Clinical presentation, treatment and outcome of Takayasu’s arteritis in southern Chinese: a multicenter retrospective study

Use of nitroglycerin ointment to treat primary and secondary Raynaud’s phenomenon: a systematic literature review

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin